A cooperative agreement-assisted program which provides support to community-based oncologists to participate in clinical trials sponsored by the clinical cooperative groups and/or cancer centres in the US.
The application guidelines for the Community Clinical Oncology Program require each CCOP to affiliate with at least one, but no more than five, NCI-supported research bases for the purpose of enrolling patients in cancer treatment and cancer control clinical trials.
In the decade since the Community Clinical Oncology Program has become operational, some clinical cooperative groups have encouraged CCOP physicians to join their scientific committees, to design protocols for the administration of clinical trials, and to chair clinical research studies, while others have discouraged, or given only weak support, to such participation.
The study period covers six time points that span two Community Clinical Oncology Program funding cycles -- CCOP-I and CCOP-II.
Study data were collected from grantee applications and progress reports as part of a larger evaluation of the Community Clinical Oncology Program.
These findings have several policy implications for the Community Clinical Oncology Program and for other kinds of health care strategic partnerships.
Brawley's professional activities have included: National Cancer Institute (NCI) Coordinator and Project Officer of the Prostate Cancer Prevention Trial, NCI Coordinator of the Minority Based Community Clinical Oncology Program, and coauthor and associate investigator in several protocols approved by the National Institutes of Health Clinical Center Investigational Review Committee.
The NCORP opportunity was established after the National Cancer Institute made the decision to end funding as of July 31, 2014 for federally-funded clinical trials in the community setting through Community Clinical Oncology Programs (CCOP).